Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP2 | P08253 | 1/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.48 |
| ▸ | CASP1 | P29466 | 2/20 | 0.48 |
| ▸ | CASP7 | P55210 | 2/20 | 0.48 |
| ▸ | CA12 | O43570 | 3/20 | 0.45 |
| ▸ | CA1 | P00915 | 3/20 | 0.45 |
| ▸ | CA2 | P00918 | 3/20 | 0.45 |
| ▸ | CA7 | P43166 | 3/20 | 0.45 |
| ▸ | CA9 | Q16790 | 3/20 | 0.45 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.45 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.45 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.43 |
| ▸ | GFER | P55789 | 1/20 | 0.43 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 3/20 | 0.42 |
| ▸ | MEN1 | O00255 | 3/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30692478 | 1.00 | MMP2 (0.52) | MMP2TDP1ALDH1A1HSD17B10CASP1 | |
| SCHEMBL686599 | 0.83 | CA12 (0.54) | ALDH1A1HSD17B10CA12CA1CA2 | |
| SCHEMBL29402442 | 0.82 | TDP1 (0.63) | MMP2TDP1ALDH1A1HSD17B10CASP1 | |
| SCHEMBL2192034 | 0.82 | TDP1 (0.63) | MMP2TDP1ALDH1A1HSD17B10CASP1 | |
| SCHEMBL7119886 | 0.82 | KDM4E (0.45) | MMP2TDP1ALDH1A1HSD17B10CASP1 | |
| SCHEMBL4306857 | 0.80 | MMP2 (0.50) | MMP2TDP1ALDH1A1HSD17B10CASP1 | |
| SCHEMBL15440294 | 0.80 | CA12 (0.43) | MMP2TDP1ALDH1A1HSD17B10CASP1 | |
| SCHEMBL8608479 | 0.79 | TDP1 (0.50) | MMP2TDP1ALDH1A1HSD17B10CASP1 | |
| SCHEMBL1549305 | 0.78 | CYP3A4 (0.68) | MMP2TDP1ALDH1A1HSD17B10CASP1 | |
| SCHEMBL22022191 | 0.78 | AKR1C3 (0.64) | MMP2TDP1ALDH1A1HSD17B10CASP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117299192-A | Hydrogenation catalyst, preparation method and application thereof | 中国石油天然气股份有限公司 | 2023-12-29 | — | — | CN | claimed |
| CN-117299209-A | Distillate oil hydrogenation catalyst and preparation method and application thereof | 中国石油天然气股份有限公司 | 2023-12-29 | — | — | CN | claimed |
| CN-110277529-B | Functional composite membrane for high-rate lithium ion battery and preparation method thereof | 新乡市中科科技有限公司 | 2021-11-05 | — | — | CN | claimed |
| CN-110277529-A | A kind of high multiplying power lithium ion battery functional composite membrane and preparation method thereof | 新乡市中科科技有限公司 | 2019-09-24 | — | — | CN | claimed |
| CN-117299192-A | Hydrogenation catalyst, preparation method and application thereof | 中国石油天然气股份有限公司 | 2023-12-29 | — | — | CN | disclosed |
| CN-117299192-A | Hydrogenation catalyst, preparation method and application thereof | 中国石油天然气股份有限公司 | 2023-12-29 | — | — | CN | disclosed |
| CN-117299209-A | Distillate oil hydrogenation catalyst and preparation method and application thereof | 中国石油天然气股份有限公司 | 2023-12-29 | — | — | CN | disclosed |
| CN-117299209-A | Distillate oil hydrogenation catalyst and preparation method and application thereof | 中国石油天然气股份有限公司 | 2023-12-29 | — | — | CN | disclosed |
| CN-110277529-B | Functional composite membrane for high-rate lithium ion battery and preparation method thereof | 新乡市中科科技有限公司 | 2021-11-05 | — | — | CN | disclosed |
| CN-110277529-A | A kind of high multiplying power lithium ion battery functional composite membrane and preparation method thereof | 新乡市中科科技有限公司 | 2019-09-24 | — | — | CN | disclosed |
| EP-1585814-B1 | FARNESYL DIBENZODIAZEPINONES, PROCESSES FOR THEIR PRODUCTION AND THEIR USE AS PHARMACEUTICALS | THALLION PHARMACEUTICALS INC (CA) | 2014-05-07 | — | — | EP | disclosed |
| US-20090263886-A1 | FARNESYL DIBENZODIAZEPINONE AND PROCESSES FOR ITS PRODUCTION | THALLION PHARMACEUTICALS INC. | 2009-10-22 | — | — | US | disclosed |
| US-7297524-B2 | Polynucleotides for production of farnesyl dibenzodiazepinones | THALLION PHARMCEUTICALS INC. (CA) | 2007-11-20 | — | — | US | disclosed |
| WO-2007102936-A2 | POLYNUCLEOTIDES FOR PRODUCTION OF FARNESYL DIBENZODIAZEPINONES | THALLION PHARMACEUTICALS INC. (CA) | 2007-09-13 | — | — | WO | disclosed |
| US-7101872-B2 | Farnesyl dibenzodiazepinone, and processes for its production | ECOPIA BIOSCIENCES, INC. (CA) | 2006-09-05 | — | — | US | disclosed |
| US-20060172395-A1 | Polynucleotides for production of farnesyl dibenzodiazepinones | ECOPIA BIOSCIENCES, INC. | 2006-08-03 | — | — | US | disclosed |
| EP-1585814-A1 | FARNESYL DIBENZODIAZEPINONES, PROCESSES FOR THEIR PRODUCTION AND THEIR USE AS PHARMACEUTICALS | Ecopia Biosciences Inc. (CA) | 2005-10-19 | — | — | EP | disclosed |
| US-20050043297-A1 | Farnesyl dibenzodiazepinone, processes for its production and its use as a pharmaceutical | ECOPIA BIOSCIENCES, INC. | 2005-02-24 | — | — | US | disclosed |
| WO-2004065591-A1 | FARNESYL DIBENZODIAZEPINONES, PROCESSES FOR THEIR PRODUCTION AND THEIR USE AS PHARMACEUTICALS | ECOPIA BIOSCIENCES INC. (CA) | 2004-08-05 | — | — | WO | disclosed |
| US-20030109682-A1 | Maytansines and maytansine conjugates | SANTI DANIEL (US) | 2003-06-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090263886-A1 | FARNESYL DIBENZODIAZEPINONE AND PROCESSES FOR ITS PRODUCTION | FDPS, GGPS1, FNTB | MMP2 4308/4885TDP1 1058/4885ALDH1A1 2196/4885 |
| US-20050043297-A1 | Farnesyl dibenzodiazepinone, processes for its production and its use as a pharmaceutical | FDPS, GGPS1, FNTB | MMP2 4468/4885TDP1 1154/4885ALDH1A1 2476/4885 |
| US-20060172395-A1 | Polynucleotides for production of farnesyl dibenzodiazepinones | FDPS, FNTA, FNTB | MMP2 4869/4885TDP1 804/4885ALDH1A1 2663/4885 |
| US-20030109682-A1 | Maytansines and maytansine conjugates | AREG, HDGF, GHITM | MMP2 396/4885TDP1 1527/4885ALDH1A1 505/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.